Notable Labs 

$0.25
19
-$0.09-27.68% Tuesday 20:00

Statistics

Day High
0.25
Day Low
0.25
52W High
4.24
52W Low
0.1
Volume
2,072,449
Avg. Volume
2,587,567
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

26FebExpected
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.73
-0.49
-0.25
-0.01
Expected EPS
-0.73
Actual EPS
N/A

Financials

-3,633.55%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
620,000Revenue
-22.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NTBL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides genomic sequencing and array-based technologies which are fundamental in personalized medicine, competing directly with Notable Labs' approach to using genetic information for cancer treatment.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health specializes in blood-based cancer diagnostics, which competes with Notable Labs' focus on personalized testing to guide cancer treatment.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Notable Labs in the field of genetic-based cancer therapy selection.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences focuses on molecular diagnostic tests, including cancer screening, which competes with Notable Labs' personalized testing for cancer treatment.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers sequencing systems that are used in genetically identifying cancer markers, competing with Notable Labs' approach in personalized oncology.
Adaptive Biotechnologies
ADPT
Mkt Cap2.64B
Adaptive Biotechnologies works on immune-driven medicine, including the use of genetic information to guide cancer treatment, competing with Notable Labs' methodologies.
Myriad Genetics
MYGN
Mkt Cap748.08M
Myriad Genetics focuses on molecular diagnostic tests that assess an individual's risk of developing cancer, competing with Notable Labs' personalized approach to cancer treatment.
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics provides tools for genomic analysis, including cancer research, which competes with Notable Labs' focus on using genomic data to personalize cancer therapy.

About

Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.
Show more...
CEO
Dror Harats
Employees
16
Country
IL
ISIN
IL0012002452

Listings

0 Comments

Share your thoughts

FAQ

What is Notable Labs stock price today?
The current price of NTBL is $0.25 USD — it has decreased by -27.68% in the past 24 hours. Watch Notable Labs stock price performance more closely on the chart.
What is Notable Labs stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Notable Labs stocks are traded under the ticker NTBL.
What is Notable Labs revenue for the last year?
Notable Labs revenue for the last year amounts to 620,000 USD.
What is Notable Labs net income for the last year?
NTBL net income for the last year is -22.53M USD.
How many employees does Notable Labs have?
As of April 04, 2026, the company has 16 employees.
In which sector is Notable Labs located?
Notable Labs operates in the Professional, Scientific, and Technical Services sector.
When did Notable Labs complete a stock split?
The last stock split for Notable Labs was on October 17, 2023 with a ratio of 1:35.
Where is Notable Labs headquartered?
Notable Labs is headquartered in 8 Hasatat St, IL.